カート
- すべて
削除
1 mg | ¥38,000 | ||
5 mg | ¥87,000 | ||
10 mg | ¥119,500 | ||
25 mg | ¥191,500 | ||
50 mg | ¥257,000 | ||
100 mg | ¥342,000 | ||
1 mL x 10 mM (in DMSO) | ¥66,500 |
Dipraglurant (ADX48621) is a negative alteration modulator (NAM) of mGluR5 that inhibits dyskinesia in the LID macaque model. | |
In vitro | The novel mGlu receptor negative allosteric modulator (NAM) bifunctional agent Dipraglurant(1-10 |
In vivo | Dipraglurant (3-30 mg/kg; single oral dose) exhibits favorable pharmacokinetics and reduces levodopa-induced dyskinesia and muscle tone disturbances without interfering with the efficacy of levodopa treatment in parkinsonian disabled monkeys [1]. |
Alias | ADX48621 |
265.29 | |
C16H12FN3 | |
CAS | 872363-17-2 |
store at low temperature,keep away from direct sunlight Powder: -20°C for 3 years | In solvent: -80°C for 1 year | ||||||||||||||||||||||||||||||||||||
DMSO: 40 mg/mL (150.78 mM) | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.